Microbot Medical Inc. announced on February 4, 2025, the acceptance of a late-breaking abstract for presentation at the upcoming Society of Interventional Radiology (SIR) annual meeting. The conference is scheduled to be held in Nashville, TN, from March 29 to April 2, 2025.
The accepted abstract will feature data from the company's ACCESS-PVI trial, which evaluated the performance and safety of the LIBERTY Endovascular Robotic System. This acceptance reflects the high interest of the SIR scientific committee in the emerging role of endovascular robotics.
Presenting at this prominent medical forum provides Microbot Medical with an opportunity to showcase the clinical findings of its pivotal trial. This exposure is crucial for educating interventional radiologists and gaining recognition within the medical community ahead of the anticipated commercial launch of LIBERTY.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.